Gillian Cannon

Director, Corcept Therapeutics.

Companies

Xenon PharmaceuticalsBoard member Aug 10, 2023 to now¹
Corcept TherapeuticsBoard member Dec 2, 2020 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Xenon Pharmaceuticals XENE1,455 shares³$50.6K at $34.78Jun 5, 2026
Corcept Therapeutics CORT0 shares⁴Sep 10, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 5, 2026Sold 1,190 shares at $53.14 of Xenon Pharmaceuticals³
Jun 1, 2026Exercised options 2,645 shares of Xenon Pharmaceuticals⁵
Sep 10, 2025Gift 7,393 shares of Corcept Therapeutics⁴
Sep 4, 2025Shares withheld for tax 3,607 shares at $70.13 of Corcept Therapeutics⁶
Sep 4, 2025Exercised options 11,000 shares at $22.99 of Corcept Therapeutics⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARXenon Pharmaceuticals, Board member
2
SEC EDGARCorcept Therapeutics, Board member
3
SEC EDGARXenon Pharmaceuticals shares after the filing of Jun 5, 2026
4
SEC EDGARCorcept Therapeutics shares after the filing of Sep 10, 2025
5
SEC EDGARForm 4 filed Jun 3, 2026
6
SEC EDGARForm 4 filed Sep 8, 2025